Nivagen Pharmaceuticals, Inc. — Form D
Nivagen Pharmaceuticals, Inc. of SACRAMENTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-09-14. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-09-14
- Form: D
- Accession: 0001716747-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Minimum investment: $10.0M
- Investors: 1
- Date of first sale: 2017-09-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-294725
Issuer
- Name: Nivagen Pharmaceuticals, Inc.
- CIK: 0001716747
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3100 FITE CIRCLE, SACRAMENTO, CA, 95827
- Phone: 916-364-1662
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Sharad Dadbhawala | Director | Campbell, CA |
| Bikram Singh | Director | Morganville, NJ |
| Dasaradhi C Lakkaraju | Executive Officer | Sacramento, CA |
| Jaswinder Matharu | Director | Douglas, Isle of Man, X0 |
| Gopal C Patel | Executive Officer | Sacramento, CA |
| Jwalant Shukla | Director | Saramento, CA |
| Jwalant Shukla | Executive Officer | Saramento, CA |
| Rob C Hart | Director | San Francisco, CA |
| Ashish C Sevak | Director | Paramus, NJ |
| Praneel C Deo | Executive Officer | Sacramento, CA |
| Michael C Kulper | Director | Sacramento, CA |
| Ashish Sevak | Director | Paramus, NJ |
| Bikramjit Singh | Director | Morganville, NJ |
Other filings by this issuer (2)
More